Our analysis of FOXC2 overexpression in mouse ovarian cancer cell lines suggests that, in addition to promoting EMT and CSC differentiation, FOXC2 might be involved in VM (path C in Figure 7). Here, FOXC2 is linked to ovarian carcinoma.